SLC6A3 and Parkinson disease: There appear to be an inverse correlation between overall striatal DAT binding and global measures of disease severity such as the H&Y stage, the total score on the Unified Parkinson’s Disease Rating Scale (UPDRS), and UPDRS activities of daily living, with a progressive decline of DAT binding with increasing disability.